Approved Study Database

Ref. No. Scientific Title Principal investigator
2012.365 A longitudinal study on the voiding function in relation to prostate condition in Hong Kong Chinese Male Prof. Ng Chi Fai
2010.018 A longitudinal survey on perceived stigmatization of mentally ill patients and its psychosocial correlates Prof Chiu F K Helen
2023.185 A Machine Learning Approach for Predicting tDCS Treatment Outcomes of Adolescent with Autism Spectrum Disorders Prof. CHAN Agnes Sui Yin
2022.140 A machine-learning approach to determine retinal characteristics for COVID-19 CT value screening Prof. ZEE Benny Chung Ying
2004.181 A Manometric Study on Pharynx and Upper Cervical Esophagus in Patients with Nasopharyngeal Carcinoma Pre- and Post-Radiotherapy CHAN Wing Kwan Anthony
2013.092 A mechanistic study of the inhibitory effect of microRNA-145 on internalization and signaling of epidermal growth factor receptors in colorectal cancer Dr. Wu William Ka-Kei
2017.221 A mechanistic study to determine the effect of extracellular histones on eryptosis and formation of extracellular vesicles/exosomes in human erythrocytes Prof. KONG Siu Kai
江紹佳
2012.335 A medical student project on family follow up - prospective, questionnaire survey on the growth of a child from birth 3 years of age in normal family environment Prof. WONG Carmen
2008.119 A Medium Term Follow Up Study on Chinese Adolescents with Anorexia Nervosa in Hong Kong Prof Lai Kelly Yee Ching
2014.383 A Methodology for Appraisal of the Acceptability on Surgical Robot for Clinical Application Prof Leung Kwok-Sui
2023.498 A mhealth social support program on health behaviors among people at risk of metabolic syndrome: a feasibility randomized controlled trial Dr. TAM Hon Lon
譚漢麟
2021.126 A Microbiome-Based Noninvasive Diagnostic Test for Early Colorectal Cancers Dr. LIANG Jessie Qiaoyi
梁巧儀
2009.184 A microRNA contribution to ezrin upregulation and Ras activation in gastric cancer Dr. Jin Hongchuan
2022.584 A mobile phone app-based intervention for supporting and empowering parents of children with autism spectrum disorder: a randomized waitlist-controlled trial Dr. WONG Oscar Wing Ho
黃永昊
2018.431 A modified approach in estimating HIV undiagnosed interval for evaluating HIV epidemiology in Hong Kong Dr. WONG Ngai Sze
王艾斯
2006.372 A Molecular Genetic Study of Psychiatric Morbidity in Stroke Prof. TANG Wai Kwong
2019.457 A Multi-Center Expanded Access Program (EAP) for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors with Rearranged During Transfection (RET) Activation (LIBRETTO-201) Dr. LOONG Herbert Ho Fung
龍浩鋒
2006.338 A Multi-Center Phase III Randomized, Double-Blind Placebo-Controlled Study of the Cancer Vaccine Stimuvax_ (L-BLP25 or BLP25 liposome vaccine) in Non-Small Cell Lung Cancer (NSCLC) Subjects with Unresectable Stage III Disease Prof. Mok S.K. Tony
2005.245 A Multi-center Prospective Randomized Phase III Trial to Determine the Benefit of Adjuvant Chemotherapy Using Gemcitabine and Cisplatin in Nasopharyngeal Carcinoma Patients with Residual EBV DNA Following Primary Radiotherapy With or Without Concurrent Cisplatin Prof. Chan T.C. Anthony
2005.414 A Multi-Center Prospective Randomized Phase III Trial to Determine the Benefit of Adjuvant Chemotherapy Using Gemcitabline and Cisplatin in Nasopharyngeal Carcinoma Patients with Residual EBV DNA Following Primary Radiotherapy with or without Concurrent Cisplatin Prof. CHAN Anthony
2016.585 A Multi-Center Retrospective Observational Study to Evaluate PD-L1 Protein Expression in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Prof. TO Ka Fai
杜家輝教授
2015.188 A multi-center retrospective study on parental decisions following prenatal diagnosis of sex chromosome aneuploidies in Hong Kong Prof. CHENG Yvonne Kwun Yue
鄭昆瑜
2008.131 A Multi-center Study of the Therapeutic Role of Continuous Positive Airway Pressure Therapy on Ischemic Stroke Survivors with Obstructive Sleep Apnoea Syndrome Prof Hui David Shu-Cheong
2008.077 A Multi-center Study of Treatment Protocol for Childhood Acute Lymphoblastic Leukemia in China, 2008 Dr Li Chi Kong
2008.391 A Multi-Center, Continuation Trial of Belimumab (HGS1006, LymphoStat-B™), A Fully Human Monoclonal Anti-BLyS Antibody, in Subjects with Systemic Lupus Erythematosus (SLE) who Completed the Phase 3 Protocol HGS1006-C1056 or HGS1006-C1057 Prof. TAM Lai Shan
2015.406 A multi-center, double blind, randomized, placebo controlled study of Testogel® (testosterone gel 50mg/5g) in the treatment of male hypogonadism Prof. KONG Alice Pik Shan
2006.258 A Multi-Center, Double-Blind, Parallel-Group, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Denagliptin in Subjects with Type 2 Diabetes Mellitus Prof. Kong Pik Shan Alice
2006.312 A Multi-Center, Double-Blind, Parallel-Group, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Denagliptin in Subjects with Type 2 Diabetes Mellitus Prof. Ko Tin Choi Gary
2003.276 A Multi-Center, Double-Blind, Randomized, Parallel Group Study to Evaluate the Effects of Two Different Doses of Losartan on Morbidity and Mortality in Patients with Symptomatic Heart Failure Intolerant of ACE Inhibitor Treatment Prof. Yu Cheuk Man
2008.515 A Multi-center, Double-blind, Randomized, Parallel Group, Placebo-controlled 12-week Study to Investigate Glycemic Parameters of Efficacy, Safety/ Tolerability and Pharmacokinetics of Five Dose Levels of RO4998452 in Patients with Type 2 Diabetes Mellitus Professor Kong Alice Pik-Shan
2008.505 A Multi-center, Double-blind, Randomized, Parallel Group, Placebo-controlled 12-week Study to Investigate Glycemic Parameters of Efficacy, Safety/Tolerability and Pharmacokinetics of Five Dose Levels of RO4998452 in Patients with Type 2 Diabetes Mellitus Prof. Brian Tomlinson
2006.421 A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Phase 2 Study to Investigate Pharmacodynamics, Safety, Tolerability and Parmacokinetics of RO5073031 in Patients with Type 2 Diabetes Mellitus Treated with a Stable Dose of Metformin Prof. Kong P.S. Alice
2006.422 A Multi-Center, Doubled-Blind, Randomized, Placebo-Controlled, Dose-Ranging Phase 2 Study to Investigate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of RO5073031 in Patients with Type 2 Diabetes Mellitus Treated with A Stable Dose of Metformin Prof. Brian Tomlinson
2016.428 A Multi-Center, International Registry to evaluate the treatment of Upper Tract Urothelial Cancer: Incidence, Indications, Treatment types and Outcomes. Dr. NG Chi Fai
吳志輝
2015.238 A multi-center, open -label study to assess the safety and efficacy of combination ceritinib (LDK378) and nivolumab in adult patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) Prof. MOK Tony Shu Kam
莫樹錦
2016.616 A multi-center, open-label, single arm, prospective study evaluating the sealing performance of the Shiley™ Laryngeal Mask in a post market clinical follow up (PMCF) Dr. CHAN Simon Kin Cheong
陳建昌
2008.135 A Multi-center, Prospective, Randomised Controlled Trial Comparing the Efficacy and Safety of PRODISC-C_ Implant to Anterior Cervical Discectomy and Fusion (ACDF) Surgery, in the Treatment of Symptomatic Cervical Disc Disease (SCDD) Prof. POON Wai Sang
2012.408 A Multi-Center, Prospective, Randomized Study Comparing Removable, Self-Expanding Metal Stents to Plastic Stents for the Treatment of Benign Biliary Strictures Secondary to Chronic Pancreatitis Prof. LAU James Y.W.
2007.229 A Multi-center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Na_ve Patients with HBeAg Negative Chronic Hepatitis due to Hepatitis B Virus Prof. Chan LY Henry
2007.227 A Multi-Center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Na_ve Patients with HBeAg Negative Chronic Hepatitis due to Hepatitis B Virus Dr. Leung WY Nancy
2007.226 A Multi-Center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Na_ve Patients with HBeAg Positive Chronic Hepatitis due to Hepatitis B Virus Dr. Leung WY Nancy
2007.228 A Multi-center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Na_ve Patients with HBeAg Positive Chronic Hepatitis due to Hepatitis B Virus Prof. Chan LY Henry
2006.026 A Multi-center, Randomized, Double-blind, Parallel Group, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Activated Recombinant Factor VII (rFVIIa/NovoSeven/NiaStase) in Severely Injured Trauma Patients With Bleeding Refractory to Standard Treatment Prof. Timothy H. RAINER
2009.489 A multi-center, randomized, double-blind, placebo-controlled clinical trial of deferasirox in patients with myelodysplastic syndromes (low/int-1 risk) and tranfusional iron overload (TELESTO) Dr. WONG Raymond Siu Ming
2009.426 A multi-center, randomized, double-blind, placebo-controlled phase III trial comparing the efficacy of bevacizumab in combination with rituximab and CHOP (RA-CHOP) versus rituximab and CHOP (R-CHOP) in previously untreated patients with CD20-positive diffuse large B-cell lymphoma (DLBCL) Dr. Lei Kenny Ieng Kit
2010.059 A Multi-center, Randomized, Double-blind, Placebo-controlled Study of AMG 785 in Skeletally Mature Adults with a Fresh Unilateral Tibial Diaphyseal Fracture Status Post Definitive Fracture Fixation with an Intramedullary Nail Professor Leung Kwok-Sui
2010.147 A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Determine the Efficacy, Safety, and Tolerability of AMG785 in Adults with Fresh Unilateral Intertrochanteric Fracture of the Proximal Femur, Status Post Fixation with a Sliding Hip Screw or Intramedullary Nail Prof. Leung Kwok Sui
2022.293 A Multi-center, Randomized, Double-Blinded, Parallel and Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients with Poor Glycemic Control via Metformin Hydrochloride Monotherapy Prof. CHOW Elaine Yee Kwan
2021.709 A Multi-center, Randomized, Double-Blinded, Parallel, Vildagliptin and Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of PB-201 in Treatment-naive Patients with Type 2 Diabetes Mellitus Prof. CHOW Elaine Yee Kwan
周怡君
2009.454 A multi-center, randomized, open-label, active-controlled study to compare the efficacy, safety and tolerability of taspoglutide (RO5073031) versus insulin glargine in insulin-naive type 2 diabetic patients inadequately controlled with metformin and sulfonylurea combination therapy Prof. Brian Tomlinson

Page 10 of 253.